Sarepta Therapeutics Overview
Sarepta Therapeutics Target Price
Analysts' average 12-month price target for Sarepta Therapeutics is $22.
Get informed when a big investor buys or sells
+ FollowShare Price
$18.99
Average Target Price
$22.25
17.2% upside
17.2% upside4 analysts in the last 4 months
High: $27 | Low: $17
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-10-08 | RBC Capital | $17 |  10.5% downside |  |
| 2026-07-27 | Morgan Stanley | $25 | 31.6% upside | |
| 2026-07-09 | Piper Sandler | $20 | 5.3% upside | |
| 2026-07-08 | Wolfe Research | $27 | 42.2% upside | |
| 2026-05-15 | Evercore ISI | $19 | 0.1% upside | |
| 2026-03-26 | Deutsche Bank | $14 | 26.3% downside | |
| 2026-03-26 | Wedbush | $35 | 84.3% upside | |
| 2026-03-12 | Mizuho SecuritiesUy Ear | $31 | 63.2% upside | |
| 2026-03-03 | JefferiesAndrew Tsai | $30 | 58% upside | |
| 2026-03-03 | Loop Capital MarketsIlya Zubkov | $25 | 31.6% upside | |
| 2026-01-27 | Robert W. Baird | $22 | 15.9% upside | |
| 2025-12-09 | Wedbush | $32 | 68.5% upside | |
| 2025-11-25 | Bernstein | $20 | 5.3% upside | |
| 2025-11-05 | Mizuho SecuritiesUy Ear | $26 | 36.9% upside | |
| 2025-11-05 | Barclays | $20 | 5.3% upside | |
| 2025-11-04 | Robert W. BairdBrian Skorney | $15 | 21% downside | |
| 2025-10-30 | Piper SandlerBiren Amin | $16 | 15.7% downside | |
| 2025-09-09 | Leerink PartnersJoseph Schwartz | $15 | 21% downside | |
| 2025-08-21 | Barclays | $22 | 15.9% upside | |
| 2025-08-15 | Deutsche BankDavid Hoang | $12 | 36.8% downside | |
| 2025-07-22 | BarclaysGena Wang | $18 | 5.2% downside | |
| 2025-07-21 | BMO CapitalKostas Biliouris | $50 | 163.3% upside | |
| 2025-07-19 | Leerink PartnersJoseph Schwartz | $10 | 47.3% downside | |
| 2025-06-25 | H.C. Wainwright | $10 | 47.3% downside | |
| 2025-06-17 | Wells FargoYanan Zhu | $75 | 294.9% upside | |
| 2025-06-16 | Cantor FitzgeraldKristen Kluska | $20 | 5.3% upside | |
| 2025-06-15 | BMO CapitalKostas Biliouris | $70 | 268.6% upside | |
| 2025-04-21 | Piper Sandler | $110 | 479.3% upside | |
| 2024-11-27 | Piper SandlerBiren Amin | $182 | 858.4% upside | |
| 2024-11-27 | NeedhamGil Blum | $202 | 963.7% upside | |
| 2024-11-07 | Cantor FitzgeraldKristen Kluska | $167 | 779.4% upside | |
| 2024-11-07 | Robert W. BairdBrian Skorney | $193 | 916.3% upside | |
| 2024-10-21 | JefferiesAndrew Tsai | $165 | 768.9% upside | |
| 2024-08-08 | Piper SandlerBiren Amin | $200 | 953.2% upside | |
| 2024-08-08 | Evercore ISIGavin Clark-Gartner | $179 | 842.6% upside | |
| 2024-08-08 | BarclaysGena Wang | $203 | 969% upside | |
| 2024-08-08 | RBC CapitalBrian Abrahams | $181 | 853.1% upside | |
| 2024-07-29 | RBC CapitalBrian Abrahams | $182 | 858.4% upside | |
| 2024-06-27 | BMO CapitalKostas Biliouris | $200 | 953.2% upside | |
| 2024-06-26 | Piper SandlerBiren Amin | $205 | 979.5% upside | |
| 2024-06-24 | Evercore ISIGavin Clark-Gartner | $185 | 874.2% upside | |
| 2024-06-24 | Mizuho SecuritiesUy Ear | $200 | 953.2% upside | |
| 2024-06-21 | Robert W. BairdBrian Skorney | $200 | 953.2% upside | |
| 2024-06-13 | Piper SandlerBiren Amin | $157 | 726.8% upside | |
| 2024-06-13 | Robert W. BairdBrian Skorney | $170 | 795.2% upside | |
| 2024-06-13 | BarclaysGena Wang | $185 | 874.2% upside | |
| 2024-06-07 | BMO CapitalKostas Biliouris | $170 | 795.2% upside | |
| 2024-05-28 | RBC CapitalBrian Abrahams | $142 | 647.8% upside | |
| 2024-05-20 | RBC CapitalBrian Abrahams | $157 | 726.8% upside | |
| 2024-05-17 | Mizuho SecuritiesUy Ear | $179 | 842.6% upside | |